VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells

Journal of Cellular Physiology

Volumn 200, Issue 3, 2004, Pages 351-359

  Fons, Pierre ^a   Herault, Jean Pascal ^a   Delesque, Nathalie ^a   Tuyaret, Joel ^a   Bono, Françoise ^a   Herbert, Jean Marc ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPILIN 1; TYROSINE KINASE RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANTIGENS, CD31; BONE MARROW CELLS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3442877507     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20076     Document Type: Article

References (30)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. 1999a. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3):221-228.
2. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. 1999b. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J 18(14):3964-3972.
3. Bernatchez PN, Rollin S, Soker S, Sirois MG. 2002. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. J Cell Biochem 85(3):629-639.
4. Ferrara N. 2000. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15-35; discussion 35-36.
5. Ferrara N. 2002. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications. Semin Oncol 29:(6 Suppl 16). 10-14.
6. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18(1):4-25.
7. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279(5356):1528-1530.
8. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267(16):10931-10934.
9. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, Fiedler W. 2000. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95(10):3106-3112.
10. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. 1998. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273(46):30336-30343.
11. Higuchi R, Fockler C, Dollinger G, Watson R. 1993. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions. Biotechnology (NY) 11(9):1026-1030.
12. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, Wijelath ES. 2001. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol 188(3):359-368.
13. Janowska-Wieczorek A, Majka M, Ratajczak J, Ratajczak MZ. 2001. Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 19(2):99-107.
14. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41-49.
15. Kabrun N, Buhring HJ, Choi K, Ullrich A, Risau W, Keller G. 1997. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124(10):2039-2048.
16. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, Tabayashi K, Shibuya M, Sato Y. 2000. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 19(17):2138-2146.
17. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M. 2000. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6(11):1229-1234.
18. Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, Reich R, Baumann H, Neufeld G. 1998. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 273(35):22272-22278.
19. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13(1):9-22.
20. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95(3):952-958.
21. Persico MG, Vincenti V, DiPalma T. 1999. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 237:31-40.
22. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. 2001. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 115(1):186-194.
23. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109(3):337-346.
24. Risau W. 1997. Mechanisms of angiogenesis. Nature 386(6626):671-674.
25. Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C. 2003. CEP-7055: A novel, orally-active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Cancer Res 63(18):5978-5991.
26. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. 2000. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106(4):571-578.
27. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. 2002. Smooth muscle progenitor cells in human blood. Circulation 106(10):1199-1204.
28. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92(6):735-745.
29. Yamada Y, Oike Y, Ogawa H, Ito Y, Fujisawa H, Suda T, Takakura N. 2003. Neuropilin-1 on hematopoietic cells as a source of vascular development. Blood 101(5):1801-1809.
30. Ziegler BL, Valtieri M, Porada GA, De Maria R, Muller R, Masella B, Gabbianelli M, Casella I, Pelosi E, Bock T, Zanjani ED, Peschle C. 1999. KDR receptor: A key marker defining hematopoietic stem cells. Science 285(5433):1553-1558.